期刊文献+

重型肝炎预后危险因素Logistic回归分析及预后模型的建立 被引量:5

Development of a prognostic factors model for severe hepatitis
下载PDF
导出
摘要 目的研究重型肝炎患者预后的危险因素,建立预后判断模型。方法回顾性收集2008年6月至2011年6月在广西医科大学第八附属医院收治的145例重型肝炎患者的临床资料,运用Logistic进行单因素和多因素分析,建立预后模型。用独立的临床肝病资料进行验证,评判模型判断能力。结果 145名患者中好转54例,死亡91例,病死率62.8%(94/145)。Logistic回归分析结果显示肝性脑病、腹水、肌酐、血氨、凝血酶原活动度是独立危险因素。对构建的预后判断模型的预测能力进行研究发现:模型预测的灵敏度为92.0%,特异度为88.0%,总正确率为90.0%。结论肝性脑病、腹水、肌酐、血氨、凝血酶原活动度作为独立的危险因素可用于预后判断模型的构建。本研究构建的预后模型能够较为准确的预测重型肝炎患者的短期预后。 Objective To generate a prognostic factors model for severe hepatitis. Methods The clinical data of 145 in - patients with se- vere hepatitis who had been treated in the Eighth Affiliated Hospital of Guangxi Medical University from June 2008 to June 2011 were retro- spectively analyzed. Logistic regression analysis was used to develop a prognostic factors model. Results Among the 145 patients, 54 re- covered and 91 died (case fatality rate: 62.8% ). Logistic regression analysis identified hepatic encephalopathy, aseites, ereatinine, ammo- nia, and prothromhin activity as independent prognostic factors of severe hepatitis. Conclusion A prognostic factors model composed of he- patic eneephalopathy, ascites, creatinine, ammonia, and prothrombin activity,can accurately predict the short - term prognosis of patients with severe hepatitis.
出处 《临床肝胆病杂志》 CAS 2012年第10期789-792,共4页 Journal of Clinical Hepatology
关键词 肝炎 病毒性 预后 危险因素 回归分析 hepatitis, viral, human prognosis risk factors regression analysis
  • 相关文献

参考文献10

二级参考文献32

  • 1余久如,杨浏.血氨酶法测定的影响因素[J].中华医学丛刊,2004,4(7):78-78. 被引量:3
  • 2陈红,袁宏,熊亚星,赵正斌,邓永东.重症肝炎生化、凝血功能检测及甲胎蛋白与预后的分析[J].临床荟萃,2005,20(22):1280-1281. 被引量:8
  • 3谷茂林.重型肝炎患者血清尿素水平的变化[J].检验医学,2006,21(1):17-17. 被引量:1
  • 4Pauwels A, Mostefa - Kaca N, Florent C, et al. Emergency liver transplantation for acute liver failure. Evaluation of London and clichy Criteria[J]. Hepatology, 1993, 17:124 -127.
  • 5Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.International Ascites Club. Hepatology, 1996, 23: 164-176.
  • 6Acharya SK, Dasarathy S, Irshad M. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality. J Hepatol, 1995, 23: 8-13.
  • 7Blei AT. Medical therapy of brain edema in fulminant hepatic failure.Hepatology, 2000, 32: 666-669.
  • 8周晓琳 丁惠国.肝硬化患者低钠血症临床分析[J].中国临床医生,2001,6:167-168.
  • 9Stockmann HB, Hiemstra CA, Marquet RL, et al. Extracorporeal perfusion for the treatment of acute liver failure. Ann Surg, 2000,231: 460-470.
  • 10Obuchi M, Yoshiba M, Sekiyama K, et al. [Serial hepatic and splenic volumetry in acute severe hepatitis]. Nippon Shokakibyo Gakakai Zasshi, 1999, 96: 147-153.

共引文献2037

同被引文献61

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部